The Local Switzerland

Swiss pharma giant Novartis to splash nine billion euros on US firm

Mon, 25 Nov 2019 15:29:06 +0100

Swiss pharmaceuticals giant Novartis announced over the weekend it would dish out $9.7 billion (8.8 billion euros) to acquire US firm Medicines Company, in a move aimed at boosting its cardiovascular treatment portfolio.

Swiss agree to extradite Chinese 'pharma spy' to US

Tue, 16 Jul 2019 20:27:04 +0200

Swiss authorities said on Tuesday they have agreed to extradite a Chinese national to the United States where he is wanted on charges of corporate espionage in the pharmaceutical industry.

Swiss giants Roche to buy US gene therapy group Spark for $4.3 billion

Mon, 25 Feb 2019 12:43:37 +0100

Swiss pharmaceutical giant Roche has announced that it has reached a $4.3 billion deal to acquire Spark Therapeutics, a US group specializing in the development of gene therapy drugs.

Swiss salaries: Bankers no longer biggest earners

Mon, 19 Nov 2018 11:28:01 +0100

The pharmaceutical industry has leapfrogged the banking sector to take top place in the Swiss earnings table, newly published data on executive salaries reveals.

Novartis slashes thousands of jobs in Switzerland and UK

Tue, 25 Sep 2018 15:53:22 +0200

Pharmaceutical giant Novartis said on Tuesday it will cut more than 2,000 jobs in Switzerland by 2022, while some 400 jobs could go in Britain as part of a global restructuring.

Novartis to buy US gene therapy group AveXis for $8.7 bn

Mon, 09 Apr 2018 10:43:09 +0200

Swiss pharmaceuticals giant Novartis announced Monday it will buy US gene therapy company AveXis for $8.7 billion (€7.1 billion).

Novartis bribery probe: ten Greek ex-ministers allegedly involved

Tue, 06 Feb 2018 11:42:28 +0100

Two former Greek prime ministers and eight former ministers have been implicated in an alleged corruption scandal involving Swiss pharmaceutical giant Novartis, a judicial source said on Monday.

Swiss pharma Novartis sees drop in profits

Tue, 18 Jul 2017 13:30:19 +0200

Swiss drugmaker Novartis on Tuesday posted a drop in first half profits amid fierce competition for generic medicines and pricing pressures but said it was set to reach annual targets.

Swiss banker resold cheap HIV drugs meant for Africa

Fri, 06 May 2016 15:39:14 +0200

A former Swiss banker illegal earned over €1 million by selling HIV medication meant for poor people in southern Africa to customers in Europe, authorities say.

Novartis drug firm faces Turkey bribe probe

Sat, 02 Apr 2016 12:15:21 +0200

Turkish prosecutors have launched an investigation into alleged corruption by Swiss pharmaceutical giant Novartis, the Anatolia news agency said on Friday.

Pharma firm Shire confirms move to Zug

Mon, 25 Nov 2013 23:14:00 +0100

The Irish-based pharma company Shire confirmed on Monday that it is moving its Swiss operations to Zug from Eysins, a village in the canton of Vaud close to Geneva.

Roche head talks up Novartis 'relationship'

Tue, 01 Oct 2013 16:47:49 +0200

The head of Swiss pharmaceutical giant Roche is open to renewed cooperation with competitor Novartis, he told the Financial Times in an interview published on Tuesday.

Novartis loses as Indian court backs generics

Mon, 01 Apr 2013 10:17:00 +0200

India's Supreme Court rejected on Monday a patent bid by Swiss drug giant Novartis, in a landmark ruling that activists say will protect access to cheap generic versions of drugs in developing nations.

Nycomed bought by Japanese pharma giant

Thu, 19 May 2011 13:28:00 +0200

Japan's Takeda Pharmaceutical said Thursday it reached a €9.6 billion ($13.6 billion) deal to buy Swiss drugmaker Nycomed in what would be one of the biggest overseas acquisitions by a Japanese firm.

Synthes agrees $21 billion takeover

Wed, 27 Apr 2011 12:32:00 +0200

Swiss-based medical technology company Synthes said on Wednesday that it had reached an agreement on a $21.3 billion takeover by US health care giant Johnson & Johnson.

Novartis profits down in first quarter

Tue, 19 Apr 2011 15:55:00 +0200

Swiss pharmaceutical giant Novartis saw its first quarter net profit fall 4.0 percent to $2.82 billion, the company announced on Tuesday.

Novartis buys Chinese vaccine maker

Tue, 22 Mar 2011 14:45:00 +0100

Swiss pharmaceutical group Novartis said on Tuesday that it had acquired 85 percent of Chinese vaccines maker Zhejiang Tianyuan Bio-Pharmaceutical company.